DE60222244T2 - Verfahren zur herstellung von zwischenverbindungen in der herstellung von discodermolid und discodermolid-analoga - Google Patents

Verfahren zur herstellung von zwischenverbindungen in der herstellung von discodermolid und discodermolid-analoga Download PDF

Info

Publication number
DE60222244T2
DE60222244T2 DE60222244T DE60222244T DE60222244T2 DE 60222244 T2 DE60222244 T2 DE 60222244T2 DE 60222244 T DE60222244 T DE 60222244T DE 60222244 T DE60222244 T DE 60222244T DE 60222244 T2 DE60222244 T2 DE 60222244T2
Authority
DE
Germany
Prior art keywords
formula
alkyl
unsubstituted
phenyl
monosubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60222244T
Other languages
German (de)
English (en)
Other versions
DE60222244D1 (de
Inventor
Guido Koch
Olivier Loiseleur
Gottfried. Sedelmeier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE60222244D1 publication Critical patent/DE60222244D1/de
Application granted granted Critical
Publication of DE60222244T2 publication Critical patent/DE60222244T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60222244T 2001-01-22 2002-01-21 Verfahren zur herstellung von zwischenverbindungen in der herstellung von discodermolid und discodermolid-analoga Expired - Fee Related DE60222244T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0101599.9A GB0101599D0 (en) 2001-01-22 2001-01-22 Organic compounds
GB0101599 2001-01-22
PCT/EP2002/000570 WO2002057251A2 (en) 2001-01-22 2002-01-21 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues

Publications (2)

Publication Number Publication Date
DE60222244D1 DE60222244D1 (de) 2007-10-18
DE60222244T2 true DE60222244T2 (de) 2008-05-29

Family

ID=9907244

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60222244T Expired - Fee Related DE60222244T2 (de) 2001-01-22 2002-01-21 Verfahren zur herstellung von zwischenverbindungen in der herstellung von discodermolid und discodermolid-analoga

Country Status (12)

Country Link
US (1) US6974875B2 (enExample)
EP (1) EP1368334B1 (enExample)
JP (1) JP4301810B2 (enExample)
CN (2) CN1775774A (enExample)
AT (1) ATE372332T1 (enExample)
AU (1) AU2002228057A1 (enExample)
BR (1) BR0206585A (enExample)
CA (1) CA2435371A1 (enExample)
DE (1) DE60222244T2 (enExample)
ES (1) ES2292726T3 (enExample)
GB (1) GB0101599D0 (enExample)
WO (1) WO2002057251A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY127609A (en) * 2000-08-07 2006-12-29 Novartis Ag Process for preparing discodermolide and analogues thereof
WO2004009574A1 (en) * 2002-07-22 2004-01-29 Novartis Ag Synthesis of discodermolide
US7321046B2 (en) 2002-09-06 2008-01-22 University Of Pittsburgh Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof
WO2004022552A1 (en) * 2002-09-06 2004-03-18 University Of Pittsburgh Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof
GB0226434D0 (en) * 2002-11-13 2002-12-18 Astrazeneca Ab Combination product
WO2005084349A2 (en) * 2004-03-02 2005-09-15 Kosan Biosciences, Inc. Compounds useful for the synthesis of (+)-discodermolide and methods therefor
US7214708B2 (en) * 2004-11-18 2007-05-08 Kosan Biosciences Incorporated Synthetic discodermolide analogs
US7816405B2 (en) 2005-04-19 2010-10-19 Eisai R&D Management Co., Ltd. Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof
WO2006115130A1 (ja) * 2005-04-19 2006-11-02 Eisai R & D Management Co., Ltd. ビス［（２ｓ）－３－［３－［（２ｓ）－３－（４－クロロ－２－シアノフェノキシ）－２－フルオロプロポキシ］フェニル］－２－イソプロポキシプロピオン酸］カルシウム及びその中間体
US7297807B1 (en) 2006-05-31 2007-11-20 The Research Foundation Of State University Of New York Intermediates for the synthesis of polypropionate antibiotics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9315802D0 (en) 1993-07-30 1993-09-15 Roussel Lab Ltd Chemical compounds
US6096904A (en) * 1996-12-03 2000-08-01 The Trustees Of The University Of Pennsylvania Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
US5789605A (en) * 1996-12-03 1998-08-04 Trustees Of The University Of Pennsylvania Synthetic techniques and intermediates for polyhydroxy, dienyl lactones and mimics thereof
WO1998048791A1 (en) * 1997-04-30 1998-11-05 The Regents Of The University Of California Synthesis of discodermolide and analogs

Also Published As

Publication number Publication date
CA2435371A1 (en) 2002-07-25
GB0101599D0 (en) 2001-03-07
ES2292726T3 (es) 2008-03-16
EP1368334B1 (en) 2007-09-05
WO2002057251A3 (en) 2002-10-10
CN1261428C (zh) 2006-06-28
WO2002057251A2 (en) 2002-07-25
EP1368334A2 (en) 2003-12-10
CN1775774A (zh) 2006-05-24
JP4301810B2 (ja) 2009-07-22
US20040073049A1 (en) 2004-04-15
BR0206585A (pt) 2003-12-16
US6974875B2 (en) 2005-12-13
JP2004517891A (ja) 2004-06-17
AU2002228057A1 (en) 2002-07-30
DE60222244D1 (de) 2007-10-18
ATE372332T1 (de) 2007-09-15
HK1060882A1 (en) 2004-08-27
CN1487929A (zh) 2004-04-07

Similar Documents

Publication Publication Date Title
EP1001951B1 (de) Thiazolderivate, verfahren zur herstellung und verwendung
WO1999007692A2 (de) Neue epothilon-derivate, verfahren zu deren herstellung und ihre pharmazeutische verwendung
EP0443449A2 (de) Verfahren zur Herstellung von Oxetanonen
DE19645361A1 (de) Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B, Teil II
DE19645362A1 (de) Verfahren zur Herstellung von Epothilon A und B und Derivaten
DE69612086T2 (de) Verfahren zur herstellung von (+)compactin und (+)mevinolin derivaten mit beta-hydroxy-delta-lactonresten
EP1161430A2 (de) Epothilon-derivate, verfahren zu deren herstellung und ihre pharmazeutische verwendung
DE60222244T2 (de) Verfahren zur herstellung von zwischenverbindungen in der herstellung von discodermolid und discodermolid-analoga
WO2000049020A2 (de) Neue epothilon-derivate, verfahren zu deren herstellung und ihre pharmazeutische verwendung
DE69920906T2 (de) Zwischenprodukte in der synthese von epothilonen und verfahren zu deren herstellung
WO2003053949A1 (de) C1-c6-epothilon-fragmente und verfahren für die herstellung von c1-c6-fragmenten von epothilonen und deren derivaten
EP0391185B1 (de) Substituierte 1,8-Naphthyridine
DE3525256A1 (de) Naphthylanaloge von mevalonolactonen und deren derivaten, verfahren zu deren herstellung und deren verwendung
DE60316456T2 (de) Neues verfahren zur herstellung von epothilone-derivaten
JP2896946B2 (ja) ネオカルジリン類の製造法
DE10138348A1 (de) Geschützte 3,5-Dihydroxy-2,2-dimethyl-valeroamide für die Synthese von Epothilonen und Derivaten und Verfahren zur Herstellung und die Verwendung
WO2006122644A2 (de) Verfahren zur herstellung von statinen
DE19735578A1 (de) Neue (C1-C6)-Fragmente, Verfahren zur Herstellung und ihre Verwendung zur Synthese von Epothilon und Epothilonderivaten
DE19813821A1 (de) Verfahren zur Herstellung von C1-C6-Bausteinen zur Totalsynthese von Epothilon und Epothilon-Derivaten
US6051721A (en) Ring E-modified analogues of(-)-podophyllotoxin and etoposide and a method for their synthesis
US6495725B2 (en) Process for the preparation of optically active enones and intermediates thereof
DE19954230A1 (de) 16-Halogen-Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
EP0818447B1 (de) 6-(Hydroxymethyl-ethyl)pyridine als HMG-CoA-Reduktase Inhibitoren
US7265229B2 (en) Method for synthesizing macrosphelides
DE19954229A1 (de) Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Ref document number: 1368334

Country of ref document: EP

Effective date: 20110802

R082 Change of representative

Ref document number: 1368334

Country of ref document: EP

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN, DE